Registry to uncover genetic cause of rare diseases

Published: 4 June 2024

Article submitted by: Garvan Institute of Medical Research

Researchers at the Garvan Institute of Medical Research are recruiting Australians with a known or suspected rare genetic disease to help improve diagnoses and treatment options for these conditions.

The Genomics of Rare Disease Registry is part of a national study focused on understanding the genetic causes of rare diseases so as to better identify, understand and manage them, and is led by Associate Professor Jodie Ingles and Associate Professor Owen Siggs at Garvan.

Through the registry, the researchers aim to pinpoint the genetic cause of rare diseases, making it possible to connect those affected to future research studies, clinical trials of new treatments, and to one another.

There are more than 7,000 known rare diseases and an estimated two million people live with a rare disease in Australia alone. Less than half of them receive a genetic diagnosis, and targeted treatments are only available for fewer than 10 per cent of patients.

“Most rare diseases are overlooked and under-researched, and the journey to a diagnosis can be long and arduous, with patients and families navigating multiple specialist visits and tests that often yield no conclusive results,” says Associate Professor Siggs, Co-Director of the Genomics and Inherited Disease Program at Garvan. “Many people with inherited diseases are suffering unnecessarily because they don’t have a genetic diagnosis. If we can get them an answer today, in some cases that can lead to a curative treatment tomorrow.”

“Understanding the genetics of a rare disease can be transformative for patients,” says Co-Director Associate Professor Ingles. “An example is inherited heart conditions referred to as cardiomyopathies — where understanding the genetic basis is helping to drive new therapies. We are working towards a future where every rare disease can be diagnosed and treated.”

The registry will gather information from Australians who have a rare disease with a known or suspected genetic cause, as well as information from their family members.

Participation in this research involves completing a 15-minute survey, providing consent to researchers accessing medical records, and providing consent to being contacted about new research opportunities. More information about the registry can be found here.


Last reviewed: July 2024

healthdirect australia logo

Proudly supported by our Government partners.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and present.

© 2026 Healthdirect Australia Limited